Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
CT ORDER

CT ORDER

Other
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML